SEC Company Response from BioCardia, Inc. (BCDA) (CIK 0000925741) (BCDA) — Jul 31, 2009
BioCardia, Inc. (BCDA) (CIK 0000925741)
Date: July 31, 2009 · CIK: 0000925741 · Accession: 0001136261-09-000229
AI Filing Summary & Sentiment
Reasoning
Letter
July 31, 2009 Letter
9701 Wilshire Blvd., Suite 1100, Beverly Hills, CA 90212
Phone (310) 274-2036
Fax (310) 271-2632
Email info@CardoMedical.com
July 31, 2009
In connection with its response to the United States Securities and Exchange Commission's comment letter, dated June 26, 2009, Cardo Medical, Inc. (the "Company") acknowledges the following:
the Company is responsible for the adequacy and accuracy of the disclosure in the filing;
staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and
the Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
CARDO MEDICAL, INC.
By: /s/ Derrick Romine
Derrick Romine
Chief Financial Officer
Show Raw Text
CORRESP 1 filename1.htm July 31, 2009 Letter 9701 Wilshire Blvd., Suite 1100, Beverly Hills, CA 90212 Phone (310) 274-2036 Fax (310) 271-2632 Email info@CardoMedical.com July 31, 2009 In connection with its response to the United States Securities and Exchange Commission's comment letter, dated June 26, 2009, Cardo Medical, Inc. (the "Company") acknowledges the following: the Company is responsible for the adequacy and accuracy of the disclosure in the filing; staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and the Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. CARDO MEDICAL, INC. By: /s/ Derrick Romine Derrick Romine Chief Financial Officer